Cresco Labs (CRLBF) Gains from Equity Investments (2020 - 2021)
Cresco Labs (CRLBF) reported Gains from Equity Investments of -$1.2 million for Q1 2021, down 730.56% on a YoY basis from $189674.0 in Q1 2020, and down 229.02% quarter-over-quarter from $927000.0 in Q4 2020.
Cresco Labs (CRLBF) Gains from Equity Investments (2020 - 2021) Analysis & Trends
Cresco Labs has reported Gains from Equity Investments for 2 years, with the latest figure at -$1.2 million in Q1 2021.
- For the quarter ending Q1 2021, Gains from Equity Investments fell 730.56% year-over-year to -$1.2 million; the trailing twelve-month figure through Dec 2021 stood at -$1.2 million (changed N/A YoY), and the FY2021 full-year result was -$1.2 million, down 201.27% from the prior year.
- Gains from Equity Investments for Q1 2021 stood at -$1.2 million, down from $927000.0 in the prior quarter.
- The five-year high for Gains from Equity Investments was $927000.0 in Q4 2020, with the low at -$1.2 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -1.20 Mn |
| Mar 31, 2021 | -1.20 Mn |
| Dec 31, 2020 | 927,000.00 |
| Dec 31, 2020 | 927,000.00 |
| Sep 30, 2020 | -134,000.00 |
| Sep 30, 2020 | -134,000.00 |
| Mar 31, 2020 | -144,000.00 |
| Mar 31, 2020 | -144,000.00 |